Hsu Mandy, Tejani Isbaah, Shah Nidhi, Olaosebikan Rasaq, Kumar Ashutosh, Naik Sunil
University Park Program, Penn State College of Medicine, State College, PA 16803, USA.
Medical College, Aga Khan University, Karachi P.O. Box 8842, Pakistan.
Children (Basel). 2024 Mar 19;11(3):367. doi: 10.3390/children11030367.
Opsoclonus-myoclonus ataxia syndrome (OMAS), also known as Kinsbourne syndrome, is a rare disorder that presents with myoclonus, ataxia, abnormal eye movements, irritability, and sleep disruptions, often in young children. We report a case of an infant barely 6 months old, with no significant past medical history, who presented to the emergency department with tremors, jerking motions of the head and arms, and rapid eye movements. After an extensive workup, she was found to have a neuroblastoma, which was subsequently surgically removed via thoracotomy. Despite an initial improvement in symptoms post-resection, the patient's symptoms recurred. She was subsequently treated with dexamethasone, intravenous immunoglobulin (IVIG), and rituximab. After treatment, the patient was noted to have mild global developmental delays but was otherwise well. This case report highlights the rare occurrence of OMAS in an infant barely 6 months old at diagnosis. Using the PubMed database, a systematic review was conducted to highlight the clinical presentation, diagnosis, and management of OMAS.
眼阵挛-肌阵挛共济失调综合征(OMAS),也称为金斯伯恩综合征,是一种罕见的疾病,通常在幼儿中出现,表现为肌阵挛、共济失调、异常眼动、易激惹和睡眠障碍。我们报告一例6个月大的婴儿,既往无重大病史,因震颤、头部和手臂抽搐动作以及快速眼动而就诊于急诊科。经过全面检查,发现她患有神经母细胞瘤,随后通过开胸手术将其切除。尽管切除术后症状最初有所改善,但患者的症状复发。随后她接受了地塞米松、静脉注射免疫球蛋白(IVIG)和利妥昔单抗治疗。治疗后,患者被发现有轻度的全面发育迟缓,但其他方面情况良好。本病例报告强调了在诊断时仅6个月大的婴儿中罕见发生OMAS的情况。使用PubMed数据库进行了系统综述,以突出OMAS的临床表现、诊断和管理。